Profiling and targeting HER2-positive breast cancer using trastuzumab emtansine

PURPOSE: This article reviews the mechanism of action of trastuzumab emtansine (T-DM1), existing clinical data relating to its use for human growth factor receptor 2 (HER2)-positive breast cancer, potential pathways of resistance, and ongoing studies evaluating this novel agent. BACKGROUND: The deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi, Saeed, Olevsky, Olga, Hurvitz, Sara A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207068/
https://www.ncbi.nlm.nih.gov/pubmed/25378946
http://dx.doi.org/10.2147/PGPM.S47524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207068/
https://www.ncbi.nlm.nih.gov/pubmed/25378946
http://dx.doi.org/10.2147/PGPM.S47524

Ejemplares similares